Clinical Trials
10 trialsNCT03486873 2026-05-26
MK-3475-587
Merck Sharp & Dohme LLC
Phase 3 Recruiting
NCT07007312 2026-05-12
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Kura Oncology, Inc.
Phase 3 Recruiting
NCT05711667 2026-05-05
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
Children's Oncology Group
Phase 3 Recruiting
NCT07504458 2026-04-16
QUATRO-APL
Quetzal Therapeutics
Phase 3 Recruiting
NCT07511127 2026-04-06
Comparing the Efficacy of Different Durations of Maribavir Treatment Regimens in Allo-HSCT
Ruijin Hospital
Phase 3 Recruiting
NCT07485855 2026-03-24
(HEM-FLU)
Asan Medical Center
Phase 3 Recruiting
NCT06652633 2026-02-05
Hesperia
Lakefront Biotherapeutics NV
Phase 3 Recruiting
NCT07186192 2026-01-28
Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy
City of Hope Medical Center
Phase 3 Recruiting
NCT04448184 2026-01-08
PATH
Ottawa Hospital Research Institute
Phase 3 Recruiting
NCT06401356 2025-06-22
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
Novartis
Phase 3 Recruiting